Maribelis Ruiz
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research 2
- Oncology top 10%
- Cytokine Signaling Pathways and Interactions 2
- Cancer Cells and Metastasis 1
-
- Angiogenesis and VEGF in Cancer 4
- Melanoma and MAPK Pathways 3
- Cell death mechanisms and regulation 1
-
- interferon and immune responses 1
-
- Glioma Diagnosis and Treatment 2
- Co-authors
- Menashe Bar‐EliJanet E. PriceEric C. McGaryDina LevCarmen S. TellezMarya F. McCartyGregory N. FullerClaudia P. Miller
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (1 paper)Molecular and Cellular Biology (1 paper)
- Partner nations
- United StatesAustraliaNetherlands
In The Last Decade
Maribelis Ruiz
11 papers receiving 669 citations
Peers
Comparison fields: 5 of 83
- Immunology and Allergy 65
- Cancer Research 150
- Oncology 240
- Molecular Biology 469
- Immunology 108
Countries citing papers authored by Maribelis Ruiz
This map shows the geographic impact of Maribelis Ruiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maribelis Ruiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maribelis Ruiz more than expected).
Fields of papers citing papers by Maribelis Ruiz
This network shows the impact of papers produced by Maribelis Ruiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maribelis Ruiz. The network helps show where Maribelis Ruiz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maribelis Ruiz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 2 | |
| 2 | Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas. | 2005 | 65 |
| 3 | 2005 | 37 | |
| 4 | 2004 | 108 | |
| 5 | 2004 | 47 | |
| 6 | 2004 | 50 | |
| 7 | 2004 | 85 | |
| 8 | 2003 | 95 | |
| 9 | Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy. | 2003 | 95 |
| 10 | 2001 | 51 | |
| 11 | 1999 | 50 |
About Maribelis Ruiz
Maribelis Ruiz is a scholar working on Immunology and Allergy, Oncology and Genetics, having authored 11 papers that have together received 685 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), Melanoma and MAPK Pathways (3 papers), Glioma Diagnosis and Treatment (2 papers), Cell Adhesion Molecules Research (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer Cells and Metastasis (1 paper), interferon and immune responses (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Immunology and Allergy (65 citations), Cancer Research (150 citations) and Oncology (240 citations). Maribelis Ruiz has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include Menashe Bar‐Eli, Janet E. Price, Eric C. McGary, Dina Lev, Carmen S. Tellez, Marya F. McCarty, Gregory N. Fuller, Claudia P. Miller, Lisa Mills and Amy B. Heimberger. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.